Blinatumomab Bridging Therapy

Conditions:   B-cell Acute Lymphoblastic Leukemia;   Refractory B Acute Lymphoblastic Leukemia;   Relapsed B-cell Acute Lymphoblastic Leukemia Intervention:   Drug: Blinatumomab Sponsors:   Michael Burke;   Amgen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Leukemia | Research